Home NDC 69097-825 Raloxifene Hydrochloride
Product NDC 69097-825
11-digit product format 690970825
Labeler code 69097
Product ID 69097-825_ebab2c47-9350-447a-9372-7ade623d5bb1
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Raloxifene
Dosage form TABLET
Route ORAL
Labeler Cipla USA Inc.
Application ANDA090842
Marketing category ANDA
Marketing start 2016-06-29
Substance RALOXIFENE HYDROCHLORIDE
Active strength 60 mg/1
Pharmacologic classes Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090842-001 RALOXIFENE HYDROCHLORIDE RALOXIFENE HYDROCHLORIDE 60MG TABLET / ORAL AB 2014-09-24
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A090842-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 A090842-001 RALOXIFENE HYDROCHLORIDE 60MG TABLET / ORAL AB 2014-09-24 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-08-01 22:54:32 2026-06 A090842-001 AB 1 a50c72e98297…
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Raloxifene Hydrochloride RALOXIFENE American Health Packaging f5c25553-1546-451d-8069-c0f484c47741 2024-05-13 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 090842 application number: ANDA090842 Raloxifene Hydrochloride RALOXIFENE Aphena Pharma Solutions - Tennessee, LLC 53a2db10-4af8-4032-b598-b7c7a0969801 2021-03-17 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 090842 application number: ANDA090842 Raloxifene Hydrochloride RALOXIFENE HYDROCHLORIDE Exelan Pharmaceuticals, Inc. 2b94ecf5-d870-4132-b455-d5ee5c9dce56 2020-09-30 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 090842 application number: ANDA090842 Raloxifene Hydrochloride RALOXIFENE Cipla USA Inc. 8fef5bfd-a786-4442-b09b-f3b81812cdac 2020-09-07 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 090842 application number: ANDA090842 ndc (product): 69097-825
Additional Listing Data#
Finished product Yes
Brand name base Raloxifene Hydrochloride
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength RALOXIFENE HYDROCHLORIDE 60 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 4F86W47BR6 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1490065 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 69097-825-02 Raloxifene Hydrochloride 30 in 1 BOTTLE TABLET 30 4 69097-825-07 Raloxifene Hydrochloride 100 in 1 BOTTLE TABLET 100 4 69097-825-15 Raloxifene Hydrochloride 1000 in 1 BOTTLE TABLET 1000 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 69097-825 RALOXIFENE HYDROCHLORIDE (RALOXIFENE) TABLET [CIPLA USA INC.] 4 Current NDC, Legacy NDC, 3 package rows 20201001_8fef5bfd-a786-4442-b09b-f3b81812cdac.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 69097-825-02 69097082502 30 TABLET in 1 BOTTLE (69097-825-02) 30 tablet 2016-06-29 0000-00-00 No No Current 69097-825-07 69097082507 100 TABLET in 1 BOTTLE (69097-825-07) 100 tablet 2016-06-29 0000-00-00 No No Current 69097-825-15 69097082515 1000 TABLET in 1 BOTTLE (69097-825-15) 1000 tablet 2016-06-29 0000-00-00 No No Current